Point32Health (Harvard Pilgrim + Tufts)
Type: Not-for-profit regional health plan (merger completed 2021) HQ: Canton, MA Members: ~2M across New England Employees: ~4,000 Revenue: ~$9.5B
Prior Relationship
None. Never contacted. Clean slate.
C-Suite
| Name | Title |
|---|---|
| Patrick Gilligan | President & CEO (since June 2025; former BCBS MA; financial recovery mandate) |
| Glenn Pomerantz, MD, JD | EVP & CMO (owns medical policy, clinical innovation, quality) |
| Katie Catlender | COO |
| Selma Ferhatbegovic | SVP, CIO |
| Jeff Weiss | EVP, Corporate Strategy (appointed Jan 2026) |
What's Going On
- Financial emergency: $534M net loss on $9.5B revenue in 2024. $96M operating loss in H1 2025. Laid off 110 in March 2025, 250+ in October 2025.
- New CEO (June 2025): Gilligan brought in specifically for financial recovery. Restructuring leadership team.
- New CMO: Pomerantz is relatively new, replaced Michael Sherman (12 years). Deep managed care background — Aetna, Cigna, Horizon BCBS, BCBS MN. MD + JD.
- Cost drivers: GLP-1s ($70M in 2024, doubling), oncology, ER utilization, behavioral health.
- Harvard Pilgrim Health Care Institute linked to Harvard Medical School — research infrastructure under CMO's portfolio.
Who to Email
Glenn Pomerantz, MD, JD — EVP & CMO. Owns medical policy, clinical innovation, quality. Career managed care executive. MD + JD means he thinks about both clinical and regulatory dimensions. Under extreme pressure to control medical cost — AI in UR conversation is immediately relevant.